First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes.
| dc.contributor.author | Chiara Garassino, Marina | |
| dc.contributor.author | Chen, Yuanbin | |
| dc.contributor.author | Paz-Ares, Luis G. | |
| dc.contributor.author | Dvorkin, Mikhail | |
| dc.contributor.author | Trukhin, Dmytro | |
| dc.contributor.author | Reinmuth, Niels | |
| dc.contributor.author | Statsenko, Galina | |
| dc.contributor.author | Voitko, Oleksandr | |
| dc.contributor.author | Hochmair, Maximilian | |
| dc.contributor.author | Ozguroglu, Mustafa | |
| dc.contributor.author | Verderame, Francesco | |
| dc.contributor.author | Havel, Libor | |
| dc.contributor.author | Losonczy, Gyorgy | |
| dc.contributor.author | Conev, Nikolay | |
| dc.contributor.author | Hotta, Katsuyuki | |
| dc.contributor.author | Ji, Jun Ho | |
| dc.contributor.author | Broadhurst, Helen | |
| dc.contributor.author | Byrne, Natalie | |
| dc.contributor.author | Thiyagarajah, Piruntha | |
| dc.contributor.author | Wade Goldman, Jonathan | |
| dc.date.accessioned | 2021-03-02T18:31:16Z | |
| dc.date.available | 2021-03-02T18:31:16Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | Chen Y., Paz-Ares L. G. , Dvorkin M., Trukhin D., Reinmuth N., Chiara Garassino M., Statsenko G., Voitko O., Hochmair M., Ozguroglu M., et al., "First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes.", JOURNAL OF CLINICAL ONCOLOGY, cilt.38, 2020 | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.other | av_ed555aa7-cf18-43cf-ace7-9099cd012b62 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/5077 | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Klinik Tıp | |
| dc.subject | Onkoloji | |
| dc.subject | ONKOLOJİ | |
| dc.title | First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes. | |
| dc.type | Makale | |
| dc.relation.journal | JOURNAL OF CLINICAL ONCOLOGY | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 38 | |
| dc.identifier.issue | 15 | |
| dc.contributor.firstauthorID | 2281671 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Makale [92796]
